Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Cantor Fitzgerald
Fish and Richardson
Moodys
Baxter
AstraZeneca
Dow
Boehringer Ingelheim

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,252,341

« Back to Dashboard

Summary for Patent: 5,252,341
Title: Tablets and granulates containing mesna as active substance
Abstract:A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain 0.01-1 parts by weight of a binding agent 0.03-0.4 parts by weight of a disintegrant 0.01-0.2 parts by weight of a lubricant and 0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
Inventor(s): Sauerbier; Dieter (Werter, DE), Engel; Jurgen (Alzenau, DE), Milsmann; Eckhard (Bielefeld, DE)
Assignee: Degussa Aktiengesellschaft (DE)
Application Number:07/930,783
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation;

Drugs Protected by US Patent 5,252,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,252,341

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany4022525Jul 16, 1990

International Family Members for US Patent 5,252,341

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 104548 ➤ Try a Free Trial
Australia 638586 ➤ Try a Free Trial
Australia 8044591 ➤ Try a Free Trial
Bulgaria 60851 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Boehringer Ingelheim
Merck
Chinese Patent Office
Cipla
Teva
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.